enow.com Web Search

  1. Ads

    related to: erbitux treatment for dogs

Search results

  1. Results from the WOW.Com Content Network
  2. Cetuximab - Wikipedia

    en.wikipedia.org/wiki/Cetuximab

    Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. [2] Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion .

  3. What Are the Possible Treatments for Cancer on My Dog's Jaw?

    www.aol.com/possible-treatments-cancer-dogs-jaw...

    Dogs with this kind of cancer that have surgery usually only survive 3 to 18 months, depending on how advanced the cancer is when found (1). Squamous cell carcinoma: This is a good possibility ...

  4. List of veterinary drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_veterinary_drugs

    pergolide – dopamine receptor agonist used for the treatment of pituitary pars intermedia dysfunction in horses; phenobarbital – anti-convulsant used for seizures; phenylbutazone – nonsteroidal anti-inflammatory drug (NSAID) phenylpropanolamine – controls urinary incontinence in dogs

  5. Toceranib - Wikipedia

    en.wikipedia.org/wiki/Toceranib

    Toceranib (INN [2]), sold under the brand name Palladia, is a receptor tyrosine kinase inhibitor that is used in the treatment of canine mast cell tumor also called mastocytoma. [3] It is the first medication developed specifically for the treatment of cancer in dogs. [4] [5] It is used as its phosphate salt, toceranib phosphate.

  6. Ivermectin Drug Interactions in Cancer Treatment for Dogs - AOL

    www.aol.com/ivermectin-drug-interactions-cancer...

    Spinosad: This flea treatment may cause ivermectin to become toxic. In a study, neurotoxic signs were found in dogs, so if she is using this medication, it can cause her to fall over and have ...

  7. Panitumumab - Wikipedia

    en.wikipedia.org/wiki/Panitumumab

    In July 2009, the FDA updated the labels of two anti-EGFR monoclonal antibody drugs (panitumumab and cetuximab) indicated for the treatment of metastatic colorectal cancer to include information about KRAS mutations. [14] This was the result of a study, which demonstrated lack of benefit with Panitumumab in patients who carried NRAS mutations. [6]

  1. Ads

    related to: erbitux treatment for dogs